Found 0 matching trials
Sandostatin LAR® Depot in Patients With Primary Insulin Hypersecretion (PIH) and at Least Moderate Obesity PHASE2 This study is in patients with at least moderate obesity (Body Mass Index \...
Show More Location
New Orleans Center for Clinical Research
Learn More & Join Trial
Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly PHASE3 This study will evaluate the efficacy and safety of pasireotide LAR 40 and ...
Show More Location
University of Michigan
Learn More & Join Trial
STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea PHASE4 Currently there is an ongoing clinical trial for patients with chemotherapy...
Show More Location
Kenmar Research Institute
Learn More & Join Trial
Safety and Efficacy Study of PTK787/ZK222584 to Treat Metastatic Neuroendocrine Tumors PHASE2 The purpose of this study is to examine if PTK787/ZK222584 (vatalanib) will...
Show More Location
Neuroendocrine Clinic
Learn More & Join Trial
Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients PHASE4 The SAUNA trial is a multi-national, multi-centre, open-label, randomised, ...
Show More Learn More & Join Trial
The Use of Drugs to Improve Kidney Function in Patients With Liver and Kidney Dysfunction PHASE2 We will address the hypothesis that refractory ascites and Type 2 hepatoren...
Show More Location
University of Alberta
Learn More & Join Trial
Efficacy and Safety of C2L-OCT-01 PR in Acromegalic Patients PHASE3 The purpose of this study is to assess the biological safety and efficacy o...
Show More Location
Republican Centre for Medical Rehabilitation and Water-therapy
Learn More & Join Trial
A Study to Evaluate Patient Experience in the Therapy of Neuroendocrine Tumors Treated With Octreotide Long Acting Release Versus Lanreotide PHASE4 This study is being done to evaluate differences in patient experience duri...
Show More Location
Memorial Sloan Kettering Basking Ridge
Learn More & Join Trial
Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor PHASE3 The purpose of this study was to evaluate whether everolimus 10 mg / day ad...
Show More Location
University of Arizona / Arizona Cancer Center Deptof Uof A/Arizona Cancer(2)
Learn More & Join Trial
Efficacy and Safety Study of Octreotide Implant in Patients With Acromegaly PHASE3 Evaluate the efficacy, safety and tolerability of the octreotide implant in...
Show More Location
Stanford University Medical Center - Stanford Hospitals and Clinics
Learn More & Join Trial